Aurora A kinase activates YAP signaling in triple-negative breast cancer

被引：0
|
作者：
S-S Chang
H Yamaguchi
W Xia
S-O Lim
Y Khotskaya
Y Wu
W-C Chang
Q Liu
M-C Hung
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular and Cellular Oncology
[2] Cancer Biology Program,Department of Breast Medical Oncology
[3] The University of Texas Graduate School of Biomedical Sciences at Houston,Department of Biotechnology
[4] Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy,undefined
[5] The University of Texas MD Anderson Cancer Center,undefined
[6] The University of Texas MD Anderson Cancer Center,undefined
[7] Center for Molecular Medicine and Graduate Institute of Cancer Biology,undefined
[8] China Medical University,undefined
[9] Sun Yat-Sen University Cancer Center,undefined
[10] State Key Laboratory of Oncology in South China,undefined
[11] Collaborative Innovation Center of Cancer Medicine,undefined
[12] Institute of Cancer Stem Cell,undefined
[13] First Affiliated Hospital Collaborative Innovation Center of Oncology,undefined
[14] Dalian Medical University,undefined
[15] Asia University,undefined
来源：
Oncogene | 2017年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Yes-associated protein (YAP) is an effector that transduces the output of the Hippo pathway to transcriptional modulation. Considering the role of YAP in cancers, this protein has emerged as a key node in malignancy development. In this study, we determined that Aurora A kinase acts as a positive regulator for YAP-mediated transcriptional machinery. Specifically, YAP associates with Aurora A predominantly in the nucleus. Activation of Aurora A can impinge on YAP activity through direct phosphorylation. Moreover, aberrant expression of YAP and Aurora A signaling is highly correlated with triple-negative breast cancer (TNBC). We herein provide evidence to establish the functional relevance of this newly discovered regulatory axis in TNBC.
引用
收藏
页码：1265 / 1275
页数：10
相关论文
共 50 条
  • [31] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [32] Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
    Ozyurt, Rumeysa
    Ozpolat, Bulent
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (07) : 818 - 832
  • [33] Prospectives of mirna gene signaling pathway in triple-negative breast cancer
    Chakkaravarthi, Kamali
    Ramesh, Rajashree
    Palaniyandi, Thirunavukkarasu
    Baskar, Gomathy
    Viswanathan, Sandhiya
    Wahab, Mugip Rahaman Abdul
    Surendran, Hemapreethi
    Ravi, Maddaly
    Sivaji, Asha
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [34] OTULIN couples WNT signaling to resistance in triple-negative breast cancer
    Wang, Wei
    Wu, Zhao-Hui
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (06)
  • [35] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Parnaz Merikhian
    Mohammad Reza Eisavand
    Leila Farahmand
    Cancer Cell International, 21
  • [36] Expression of mTOR Signaling Pathway Molecules in Triple-Negative Breast Cancer
    Ito, Kei
    Ogata, Hideaki
    Honma, Naoko
    Shibuya, Kazutoshi
    Mikami, Tetuo
    PATHOBIOLOGY, 2019, 86 (5-6) : 315 - 321
  • [37] The baffling effect of bafilomycin on Notch signaling in triple-negative breast cancer
    Pamarthy, Sahithi
    Jaiswal, Mukesh K.
    Kulshrestha, Arpita
    Katara, Gajendra
    Ibrahim, Safaa
    Gilman-Sachs, Alice
    Beaman, Kenneth D.
    CANCER RESEARCH, 2015, 75
  • [38] Triple-negative breast cancer: understanding Wnt signaling in drug resistance
    Merikhian, Parnaz
    Eisavand, Mohammad Reza
    Farahmand, Leila
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [39] PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis
    A Paul
    S Gunewardena
    S R Stecklein
    B Saha
    N Parelkar
    M Danley
    G Rajendran
    P Home
    S Ray
    I Jokar
    G A Vielhauer
    R A Jensen
    O Tawfik
    S Paul
    Cell Death & Differentiation, 2014, 21 : 1469 - 1481
  • [40] PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis
    Paul, A.
    Gunewardena, S.
    Stecklein, S. R.
    Saha, B.
    Parelkar, N.
    Danley, M.
    Rajendran, G.
    Home, P.
    Ray, S.
    Jokar, I.
    Vielhauer, G. A.
    Jensen, R. A.
    Tawfik, O.
    Paul, S.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (09): : 1469 - 1481
12345